Home > Browse > Healthcare > Tempus Oncology

Tempus Oncology

Tempus Oncology is an AI-powered Healthcare tool — AI precision medicine and cancer genomics. Best for: Art Generation & Data Analysis. Pricing: Paid (GateOnAI Score: 48/100).

AI precision medicine and cancer genomics

PaidVerifiedArt GenerationData AnalysisData VisualizationPredictive AnalyticsMedical ImagingAI AssistantNatural Language ProcessingMachine Learning

Analyzes tumor DNA and RNA to produce a comprehensive molecular profile that feeds an AI engine for variant classification, therapeutic relevance scoring, and resistance prediction. Offers whole-exome sequencing, targeted gene panels, and liquid biopsy options, each with validated sensitivity thresholds. Generates a structured report that integrates with electronic health records, displays actionable mutations, and links to FDA‑approved drugs or clinical trials. Maintains a real‑world outcomes database that updates treatment efficacy metrics as new cases are entered. Provides a web‑based dashboard where clinicians can filter cohorts, compare biomarker frequencies, and export data for research.\nServes oncologists, pathologists, and research hospitals that need rapid, evidence‑based treatment recommendations. Enables physicians to match patients to targeted therapies, assess likely resistance mechanisms, and enroll eligible cases in precision‑medicine trials. Supports multidisciplinary tumor boards by supplying concise, visual summaries of genomic findings. Pricing is a paid subscription model billed per institution, with tiered rates based on test volume and data‑access features. No free tier exists; contracts typically include laboratory processing fees and optional analytics add‑ons.\nCompared with rivals such as Foundation Medicine and Guardant Health, Tempus delivers a broader panel of RNA‑based expression markers and a larger curated outcomes repository. Turnaround time averages ten business days for tissue samples, faster than many lab‑based sequencing services. Compliance follows HIPAA and CLIA standards, facilitating integration into hospital workflows. Limitations include the need for sufficient tumor material, higher per‑test cost than some panel‑only providers, and current focus on solid tumors rather than hematologic malignancies.

Visit Tempus Oncology

More Healthcare Tools

Works Well With

Tools that Tempus Oncology genuinely connects with, based on real input/output compatibility data (not just shared category):

Find similar tools | Browse all AI prompts